ISPO

Prognostic Markers

Autoantibodies to subunits of Replication Protein A (RPA) in sera of patients with malignancies

F Fernàndez-Madrid, MD, PhD, JL Granda, MD, PhD, P Gimotty, PhD, P Vandevord, MJ Kraut, MD, Xin Yang, JE Tomkiel, PhD

Cyclin D1 is an indicator of poor prognosis in resectable non-small cell lung cancer

JS Keum, MD PhD , G Kong, MD, SC Yang, MD PhD, DH Shin, MD PhD, SS Park, MD PhD, JH Lee, MD PhD, JD Lee, MD PhD

AgNOR and Ki-67 as prognostic indicators in adenoid cystic carcinoma of the head and neck

S Nordgård , MD PhD, G Franzén , MD PhD, M Boysen , MD PhD

Frequent chromosomal gains at 17q and 5p in gallbladder cancers and 12p gain as a prognostic factor

S Yoshida MD, M Hirai MD, T Todoroki, MD, H Kashiwagi MD, N Koike, MD, T Kawamoto, MD, T Kawamura MD, T Ishikawa MD, M Miwa MD, and K Uchida MD

Microsatellite instability is associated with tumor progression of gastric cancers

G Kong, MD, JS Keum, MD, HS Yoon, BS, CY Park, MD, JD Lee, MD

Predictive value of p53 autoantibodies in head and neck neoplasms

JP Metges MD, G Potard, JF Morin , JA Jezequel, JP Labat MD

Telomerase activity in human carcinomas

P Iniesta PhD , R Gonzàlez-Quevedo , MJ Massa , C de Juan PhD , A Sànchez MD , AJ Torres MD , FJ Cerdàn MD , JL Balibrea MD

α-L-fucosidase enzyme in the prediction of colorectal cancer patients at high risk of tumour recurrence

J Fernàndez-Rodríguez PhD, D Ayude BSc, M Pàez de la Cadena PhD, A Caride Castro BSc, G de Castro MD , VS Martínez-Zorzano PhD, A de Carlos PhD & FJ Rodríguez-Berrocal PhD

Isoform-specific gene expression of metallothionein in prostate cancer: potential role in disease progression

AB Abdel-Mageed DVM PhD, R Davis MD

p53 protein expression in uveal melanomas as prognostic marker

IM Greco MD PhD, E Balestrazzi MD, F Cerrito, G Calvisi MD

Immunohistochemical detection of proliferating cell nuclear antigen and relationship with conventional pathological prognostic parameters in uveal melanomas

IM Greco MD PhD, G Calvisi MD, L Spadea MD, E Balestrazzi MD

Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and oropharynx.

C Martín de Vidales MD PhD, A Zapatero MD PhD, L Cerezo MD PhD, A.Marin, A Pérez Torrubia MD

CYFRA 21-1 is an useful marker of survival and therapeutic effect in lung cancer

Y Takei MD , K Minato MD , A Takise MD , S Tsuchiya MD , R Saito MD , M Mori MD

Relationship of histology, proliferative activity, DNA and p53 values in phyllodes tumor of the breast

A Niezabitowski MD , PhD, B Lackowska PhD , A Kruczak MSc , J Rys MD PhD , J Mitus MD PhD , M Reinfuss MD PhD

Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: Association with poor survival

M Gentile , K Olsen , M Dufmats and S Wingren

The molecular forms of urokinase receptor in blood plasma and tumor tissue from breast and colon cancer patients

RW Stephens PhD, G Høyer-Hansen PhD, MJAG Hamers, H-J Nielsen MD DMSc, K Danø MD DMSc, N Brünner MD DMSc

Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB and EGFR in cervical carcinomas

H Skomedal, MSc , GB Kristensen, MD , AK Lie, MD , and R Holm, PhD

Immunohistochemical expression of pS2 protein in endometrial carcinomas: correlation with clinico-pathology, sex steroid receptor status and prognosis

M Koshiyama MD, M Yoshida MD, H Fujii MD, M Konishi MD, M Takemura MD, Y Yura MD, K Matsushita MD, H Nanno MD., M Hayashi MD and K Tauchi MD

Topoisomerase IIα and c-erbB-2 correlate in ovarian cancer and both are associated with survival

J Lange , A Kett MD , B Tanner MD , F Oesch , S Gebhard MD , JG Hengstler MD

The CAG and GGC repeats within the androgen receptor gene: reliable prognostic molecular markers in prostate cancer?

S Gonbert, C Mestayer, A Willemsen, F Jaubert MD, B Aral MD, JP Lagarde, B Dufour MD, I Mowszowicz MD

PSP94 (prostate secretory protein of 94 amino acids) expression in prostate cancer: Correlation with tumor grade, pathological stage and serum PSA levels

M Moussa MBBCh , Y Imasato MD , J Chin MD , H Sakai MD , J Xuan PhD

Prognostic significance of β-microseminoprotein mRNA expression in prostate cancer

H Sakai MD , TTsurusaki MD , S Kanda MD , T Koji PhD , Y Saito MD

Stereologically estimated mean nuclear volume of prostatic cancer as an excellent prognostic parameter

K Arima MD , T Hioki MD , A Yamashita MD , M Yanagawa MD , Y Sugimura MD , J Kawamura MD

Hospital based prostate specific antigen screening

M Vogl MD , MM Müller MD , W Höltl MD

CGH for genetic characterization of metastatic renal cell carcinoma

Kerstin Junker MD ; V Janitzky MD ; P Moravek MD ; M Podhola MD ; J Schubert Prof

Expression of p53 protein in early invasive colorectal carcinomas with particular attention to correlation with metastasis and recurrence

K Hirano, M Mizoguchi MD, Y Takahashi MD M Mai MD, T Minamoto MD

Acute leukemias expressing p210- and p190-type bcr/abl mRNAS: Report of three cases and review of the literature

Sayuri Yamashita MD, T Umemura MD, S Sadamura MD, H Takahira MD, J Nishimura MD, H Nawata MD, M Katsuno MD, N Uike MD, J Okamura MD

Nosocomial and community-acquired episodes of bacteraemia from 1990 to 1997 in patients with hematological malignancies: risk factors and prognostic indicators

E Tacconelli MD , M Tumbarello MD , F Leone MD , T Spanu MD , L Mele MD , C Vergine MD , R Cauda MD , L Pagano MD

Association of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors

TM Proebstle MD, W Jiang MD, U Leiter MD, J Hoegel MD , L Weber MD, C Voit MD

Melanoma inhibiting activity: a new prognostic serum marker in patients with malignant melanoma

L-O.Hansson MD, PhD , E.Djureen-Mårtenson MD , B.Nilsson BS , J.Hansson MD, PhD , E.von Schoultz MD, PhD , U.Ringborg MD, PhD

Microvessel density and tissue concentration of vascular endothelial growth factor in soft tissue sarcoma

K Yudoh MD, M Kanamori MD PhD, K Ohmori MD PhD, T Yasuda MD

Synthesis of MXR7 is decreased in hepatocellular carcinoma (HCC)

H LagePhD, M Dietel MD

Inhibition of the DNA binding activity of the Ku protein in bladder carcinoma

S Pucci, MG Toscano, A Mecozzi, E Cruciani, D Frasca, D Tirindelli Danesi